Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-21

Clinical Trial Update: Intermittent Preventive Treatment for Malaria in Patient With Sickle Cell Disease [Phase 1, Phase 2]

View source ↗

Summary

This entry reports the completion status of a Phase 1/2 trial evaluating intermittent preventive treatment for malaria in people with sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria, Sickle Cell Crisis | Phase 1, Phase 2 | Status: COMPLETED